课题基金 / 基金详情

Clarification of the underlying mechanism of allergic diseases targeting the signal pathways of the involved cytokines

Clarification of the underlying mechanism of allergic diseases targeting the signal pathways of the involved cytokines
阐明针对相关细胞因子信号通路的过敏性疾病的潜在机制
批准号:
18604007
负责人:
IZUHARA Kenji
金额:
$2.69万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

IZUHARA Kenji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We found in this study that periostin, an extracellular matrix protein, is a component of fibrosis in bronchial asthma and that pendrin, an anion exchanger, is a mediator for mucus production in bronchial asthma and chronic obstructive pulmonary disease (COPD). In the former project, we obtained the following results. (1) Upon stimulation of IL-4/IL-13, lung fibroblasts secreted periostin. (2) Periostin was deposited in the fibrotic legions of asthma. (3) Periostin bound to other matrix proteins such as tenascin-C, fibronectin, and collagen V. These results suggest that periostin is secreted from lung fibroblasts stimulated with IL-4/IL-13 in bronchial asthma and is involved in fibrosis of asthma by binding to other matrix proteins. In the latter project, we obtained the following results. (1) Bronchial epithelial cells cultured by the air-interface method in the presence of IL-13 differentiated into mucus-producing cells and these cell expressed pendrin. (2) Expression of pendrin was up-regulated in lung tissues of bronchial asthma and COPD. (3) Enforced expression of pendrin in airway cells caused mucus production. (4) Enforced expression of pendrin into mouse lungs caused mucus production with infiltration of neutrophils. These results suggest that pendrin is induced in the lung tissues of bronchial asthma and COPD and is involved in mucus production in these diseases. Fibrosis and mucus production are deeply correlated with morbidity and mortality of bronchial asthma and COPD. Therefore, the present results are useful to comprehend the whole molecular mechanism of fibrosis and mucus production in bronchial asthma and COPD and to develop therapeutic reagents against these phenotypes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
オーダーメイド医療を目指したアレルギー疾患診断の確立
建立过敏性疾病诊断体系,实现个体化医疗
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [松永和人, 柳澤悟, 市川朋宏, 赤松啓一郎, 小荒井晃, 平野綱彦, 杉浦久敏, 南方良章, 一ノ瀬正和, 出原 賢治]
通讯作者: 出原 賢治
DOI: 10.2332/allergolint.55.361
发表时间: 2006-12-01
期刊: Allergology international : official journal of the Japanese Society of Allergology
影响因子: --
作者: [Izuhara, Kenji, Saito, Hirohisa]
通讯作者: Saito, Hirohisa
Effect of IL-13 receptor α2 levels on the biological activity of IL-13 variant R110Q
IL-13受体α2水平对IL-13变体R110Q生物活性的影响
DOI: --
发表时间: 2007
期刊: J Allergy Clin Immunol 120
影响因子: --
作者: [Kanaji, S, Kanaji S, Izuhara K, Nakao I, Izuhara K, Andrews AL]
通讯作者: Andrews AL
Expression of human IL-13 receptor α2 extracellular domain in Pichia pastoris
人IL-13受体α2胞外结构域在毕赤酵母中的表达
DOI: --
发表时间: 2007
期刊: Protein Expres Purif 56
影响因子: --
作者: [Kanaji, S, Kanaji S, Izuhara K, Nakao I, Izuhara K, Andrews AL, Hayashi N, Kanaji S, Ohkuri T]
通讯作者: Ohkuri T
26
    Clarification of the functional roles of matrix proteins in the pathogenesis of allergic inflammation
    • 批准号:
      23591465
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      IZUHARA Kenji
    • 依托单位:
    Functional analysis of novel effectors correlated with allergic diseases
    • 批准号:
      20591188
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      IZUHARA Kenji
    • 依托单位:
    Clarification of the mechanism of allergic diseases based on the analyses of the mechanism of signal transduction of interleukin-4 and-13
    Identification of atopy genes and analyses of their functions
    海外基金